Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis (2011)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; TAKAYANAGUI, OSVALDO MASSAITI - FMRP ; BONATO, PIERINA SUELI - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1111/j.1365-2125.2011.03945.x
- Subjects: FARMACOCINÉTICA; ANTIPARASITÁRIOS; CISTICERCOSE (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Source:
- Título: British Journal of Clinical Pharmacology
- ISSN: 0306-5251
- Volume/Número/Paginação/Ano: v. 72, n. 1, p. 77-84, 2011
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
GARCIA, Hector H. et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British Journal of Clinical Pharmacology, v. 72, n. 1, p. 77-84, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2011.03945.x. Acesso em: 29 dez. 2025. -
APA
Garcia, H. H., Lescano, A. G., Lanchote, V. L., Pretell, E. J., Gonzales, I., Bustos, J. A., et al. (2011). Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British Journal of Clinical Pharmacology, 72( 1), 77-84. doi:10.1111/j.1365-2125.2011.03945.x -
NLM
Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis [Internet]. British Journal of Clinical Pharmacology. 2011 ; 72( 1): 77-84.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1111/j.1365-2125.2011.03945.x -
Vancouver
Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis [Internet]. British Journal of Clinical Pharmacology. 2011 ; 72( 1): 77-84.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1111/j.1365-2125.2011.03945.x - Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma
- Análise do albendazol sulfóxido e albendazol sulfona em plasma empregando LC-MS/MS
- Medical management of neurocysticercosis
- Silmutaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma
- Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis
- Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry
- Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis
- Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis
- Quantificação cromatográfica da cafeína e metabólitos em urina para avaliação da atividade CYP1A2
- Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics
Informações sobre o DOI: 10.1111/j.1365-2125.2011.03945.x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
